Cannabis stocks
161.98k followers • 18 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis
Curated by Yahoo Finance
Global spending on legal cannabis worldwide will hit over £43 billion in a decade, according to Arcview Market Research and BDS Analytics. Driven by the legalisation of recreational and medical cannabis and the increasing demand for both, legal cannabis revenue in the US is projected to hit £17.8 billion by 2022. Yahoo Finance is now tracking the major players in the cannabis industry.
How do we pick these stocks?This is a curated list, powered by Yahoo Finance’s algorithm and intelligence from our millions of users as well as the Yahoo Finance editorial team. The list covers companies in horticulture, pharmaceutical research and ancillary businesses. We will continue to add names as corporations invest and pivot into the space.
How are these weighted?The stocks on this watchlist are weighted equally at the time they were added.
To learn what every company on this list is doing that involves cannabis, read this story.
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| Cannabis stocks | -0.61% | +58.10% | -9.72% | +327.19% |
| ^GSPC | -1.51% | -8.63% | -16.62% | +3755.51% |
18 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie Inc. | 134.21 | -8.51 | -5.96% | 16:03 GMT-4 | 14.91M | 5.51M | 237.27B |
| BUD | Anheuser-Busch InBev SA/NV | 45.16 | -0.28 | -0.62% | 16:00 GMT-4 | 2.65M | 1.39M | 79.13B |
| MO | Altria Group, Inc. | 40.38 | -0.79 | -1.92% | 16:03 GMT-4 | 8.57M | 8.36M | 74.18B |
| TAP | Molson Coors Brewing Company | 47.99 | -0.18 | -0.37% | 16:05 GMT-4 | 1.35M | 1.45M | 10.44B |
| SMG | The Scotts Miracle-Gro Company | 42.75 | -1.37 | -3.11% | 16:00 GMT-4 | 1.44M | 624.25k | 2.35B |
| WEED.TO | Canopy Growth Corporation | 3.75 | -0.07 | -1.83% | 15:59 GMT-4 | 1.35M | 2.70M | 1.48B |
| TLRY | Tilray Brands, Inc. | 2.75 | -0.11 | -3.85% | 16:00 GMT-4 | 11.86M | 24.78M | 1.31B |
| CGC | Canopy Growth Corporation | 2.73 | -0.05 | -1.80% | 16:00 GMT-4 | 4.22M | 11.84M | 1.15B |
| CRON | Cronos Group Inc. | 2.82 | -0.11 | -3.75% | 16:00 GMT-4 | 1.49M | 1.91M | 1.05B |
| ACB | Aurora Cannabis Inc. | 1.22 | -0.03 | -2.40% | 16:00 GMT-4 | 4.82M | 9.74M | 241.89M |
| TGODF | The Green Organic Dutchman Holdings Ltd. | 0.0388 | -0.00 | -3.72% | 15:54 GMT-4 | 56.24k | 353.77k | 20.82M |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 0.165 | -0.01 | -5.61% | 16:00 GMT-4 | 256.69k | 951.40k | 20.66M |
| CANN | General Cannabis Corp | 0.19 | +0.00 | +2.70% | 15:57 GMT-4 | 47.72k | 49.25k | 16.11M |
| NBEV | New Age Beverages Corporation | 0.0935 | - | - | 16:00 GMT-4 | 47.16M | 10.83M | 13.73M |
| MJ | ETFMG Alternative Harvest ETF | 4.59 | -0.07 | -1.50% | 16:00 GMT-4 | 631.09k | 1.32M | - |
- TheStreet.com
How Far Will AbbVie's Humira Revenue Fall in 2023?
The world's best-selling drug begins losing patent protections next year. AbbVie's revenue could take years to recover.
- The Telegraph
Surging dollar means parity still a threat despite pound revival
After a rollercoaster ride, the pound has pulled back from the brink of parity with the dollar, defying the doubters who suggested it was all but inevitable at the start of the week.
- Motley Fool
Here's Why This Dividend King Is a Buy
Among the most notable stocks to do so, AbbVie (NYSE: ABBV) is actually trading up 6% on the year. AbbVie is best known as the maker of the top-selling drug in the world, Humira. This stacked lineup of products explains how the drugmaker's net revenue increased 4.5% year over year to $14.6 billion in the second quarter.
